Correlation Between Aerovate Therapeutics and Oric Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Oric Pharmaceuticals, you can compare the effects of market volatilities on Aerovate Therapeutics and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Oric Pharmaceuticals.
Diversification Opportunities for Aerovate Therapeutics and Oric Pharmaceuticals
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aerovate and Oric is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Oric Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Oric Pharmaceuticals
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.05 times more return on investment than Oric Pharmaceuticals. However, Aerovate Therapeutics is 1.05 times more volatile than Oric Pharmaceuticals. It trades about 0.22 of its potential returns per unit of risk. Oric Pharmaceuticals is currently generating about 0.08 per unit of risk. If you would invest 219.00 in Aerovate Therapeutics on August 31, 2024 and sell it today you would earn a total of 45.00 from holding Aerovate Therapeutics or generate 20.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. Oric Pharmaceuticals
Performance |
| Timeline |
| Aerovate Therapeutics |
| Oric Pharmaceuticals |
Aerovate Therapeutics and Oric Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and Oric Pharmaceuticals
The main advantage of trading using opposite Aerovate Therapeutics and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.| Aerovate Therapeutics vs. Cue Biopharma | Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. Inhibrx | Aerovate Therapeutics vs. Molecular Partners AG |
| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |